Advances in the supportive care and treatment of hematologic malignancies have markedly improved the life expectancy of afflicted patients, but this progress is increasingly at the expense of developing a wider range of infectious complications often caused by drug-resistant organisms. The clinical approach to infections occurring among hematology patients involves understanding host immune system defects and anatomic barrier disruption that predispose patients to infection (Figure 91-1). This chapter reviews specific hematologic conditions for their unique host defence defects and associated infections (Table 91–1), and the differential diagnoses of common infectious pathogens (Table 91–2). To demonstrate how periods of predictable anatomic defects combine with severe immune compromise, the prevention, diagnosis, and management strategies for infections occurring in the hematopoietic stem cell transplantation (HCT) recipient are presented as models.

Chapter 91. Clinical approach to infections in the immunocompromised host

LEWIS, RUSSEL EDWARD;
2013

Abstract

Advances in the supportive care and treatment of hematologic malignancies have markedly improved the life expectancy of afflicted patients, but this progress is increasingly at the expense of developing a wider range of infectious complications often caused by drug-resistant organisms. The clinical approach to infections occurring among hematology patients involves understanding host immune system defects and anatomic barrier disruption that predispose patients to infection (Figure 91-1). This chapter reviews specific hematologic conditions for their unique host defence defects and associated infections (Table 91–1), and the differential diagnoses of common infectious pathogens (Table 91–2). To demonstrate how periods of predictable anatomic defects combine with severe immune compromise, the prevention, diagnosis, and management strategies for infections occurring in the hematopoietic stem cell transplantation (HCT) recipient are presented as models.
2013
Hematology
692
701
Shelbourn S; Lewis Russell E.; Kontoyiannis D.P.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/414168
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact